Spermine and Citrate as Metabolic Biomarkers for Assessing Prostate Cancer Aggressiveness

Separating indolent from aggressive prostate cancer is an important clinical challenge for identifying patients eligible for active surveillance, thereby reducing the risk of overtreatment. The purpose of this study was to assess prostate cancer aggressiveness by metabolic profiling of prostatectomy...

Full description

Bibliographic Details
Main Authors: Giskeødegård, Guro F., Bertilsson, Helena, Selnæs, Kirsten M., Wright, Alan J., Bathen, Tone F., Viset, Trond, Halgunset, Jostein, Angelsen, Anders, Gribbestad, Ingrid S., Tessem, May-Britt
Format: Online
Language:English
Published: Public Library of Science 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3633894/